TNFA Rasio cepet TNF Pharmaceuticals Inc.

This daily price chart for TNF Pharmaceuticals (TNFA) captures the 0.93 metric. The company's operations are limited to basic waste utilization and laboratory energy efficiency. The business relies on developing a system to combat age-related inflammation through patent protection of the empresan platform. Meanwhile, financial stability depends on the results of clinical trials and commercialization permits for treatments targeting metabolic disorders.

To assess issuer reliability, it is critical to understand a company's ability to meet immediate obligations. This indicator compares cash and accounts receivable against short-term debt, completely excluding slow-moving inventories. For TNF Pharmaceuticals (TNFA), such reserves are vital for protecting intellectual property and covering R&D costs. The month-over-month quick liquidity trend clearly demonstrates the business's resilience to cash flow gaps.